CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $91,606 | -13.6% | 15,686 | 0.0% | 0.00% | – |
| Q3 2022 | $106,000 | +32.5% | 15,686 | -33.8% | 0.00% | – |
| Q1 2022 | $80,000 | +81.8% | 23,681 | +128.6% | 0.00% | – |
| Q2 2021 | $44,000 | -88.3% | 10,357 | -86.3% | 0.00% | – |
| Q1 2021 | $377,000 | -58.6% | 75,468 | +4.9% | 0.00% | – |
| Q4 2020 | $910,000 | +32.7% | 71,968 | +3.1% | 0.00% | – |
| Q3 2020 | $686,000 | -4.3% | 69,825 | -3.0% | 0.00% | – |
| Q2 2020 | $717,000 | +20.7% | 71,998 | +7.3% | 0.00% | – |
| Q1 2020 | $594,000 | +25.3% | 67,125 | +30.8% | 0.00% | – |
| Q4 2019 | $474,000 | +64.6% | 51,302 | +5.1% | 0.00% | – |
| Q3 2019 | $288,000 | -50.9% | 48,827 | 0.0% | 0.00% | – |
| Q2 2019 | $586,000 | +5.0% | 48,827 | +5.8% | 0.00% | – |
| Q1 2019 | $558,000 | -0.5% | 46,169 | +3.4% | 0.00% | – |
| Q4 2018 | $561,000 | -60.3% | 44,640 | -53.1% | 0.00% | -100.0% |
| Q3 2018 | $1,413,000 | -11.8% | 95,187 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,602,000 | -20.3% | 95,187 | +8.6% | 0.00% | -50.0% |
| Q1 2018 | $2,009,000 | +111.9% | 87,687 | +139.4% | 0.00% | +100.0% |
| Q4 2017 | $948,000 | +100.0% | 36,621 | +14.0% | 0.00% | – |
| Q3 2017 | $474,000 | +5.6% | 32,122 | 0.0% | 0.00% | – |
| Q2 2017 | $449,000 | +21.0% | 32,122 | +47.9% | 0.00% | – |
| Q1 2017 | $371,000 | +65.6% | 21,722 | 0.0% | 0.00% | – |
| Q4 2016 | $224,000 | +1.8% | 21,722 | 0.0% | 0.00% | – |
| Q3 2016 | $220,000 | -50.1% | 21,722 | -44.6% | 0.00% | -100.0% |
| Q2 2016 | $441,000 | -17.7% | 39,226 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $536,000 | -5.0% | 39,226 | +32.2% | 0.00% | 0.0% |
| Q4 2015 | $564,000 | +1.1% | 29,679 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $558,000 | +72.2% | 29,679 | +36.6% | 0.00% | – |
| Q2 2015 | $324,000 | – | 21,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |